Individuals with FH can be identified through clinical methods such as collecting a family health history and completing a blood test to check cholesterol levels as well as through genetic testing for pathogenic variants in the main three genes associated with FH, LDLR, APOB, and PCSK9 [1, 3]. Here, PCSK9 is linked to familial hyperaldosteronism.